REFERENCES
- Pappas G, Papadimitriou P, Akriditis N, . The new global map of human brucellosis. Lancet Infect Dis. 2006;6:91–99.
- Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med. 2005;352:2325–2336.
- Namiduru M, Gungor K, Dikensoy O, . Epidemiological, clinical and laboratory features of brucellosis: a prospective evaluation of 120 adult patients. Int J Clin Pract. 2003;57:20–24.
- Sari R, Buyukberber N, Sevinc A, . Brucellosis in the etiology of febrile neutropenia: case report. J Chemother. 2002;14:88–91.
- Ozcay F, Derbent M, Ergin F, . Febrile neutropenia caused by Brucella melitensis in a child with hypoplastic acute lymphoblastic leukemia. Med Pediatr Oncol. 2000;35:496–497.
- Metan G, Sardan YC, Hascelik G. Brucellosis in all patients with febrile neutropenia. Leuk Lymphoma. 2006;47:954–956.
- Arda B, Tasbakan MI, Pullukcu H, . Brucella melitensis in the aetiology of febrile neutropenia: report of two cases brucellosis and febrile neutropenia. Int J Clin Pract. 2007;61:1233–1238.
- Pappas G, Memish ZA. Brucellosis in middle East: a persistent medical, socioeconomic and political issue. J Chemother. 2007;19:243–248.
- Al Sekait MA. Seroepidemiological survey of brucellosis antibodies in Saudi Arabia. Ann Saudi Med. 1999;19:219–222.
- Karabay O, Serin E, Tamer A, . Hepatitis B carriage and Brucella seroprevalence in urban and rural areas of Bolu province of Turkey: a prospective epidemiologic study. Turk J Gastroenterol. 2004;15:11–13.
- Lubani MM, Dudin KI, Sharda DC, . A multicenter therapeutic study of 1100 children with brucellosis. Pediatr Infect Dis J. 1989;8:75–78.
- Roushan MR, Mohraz M, Janmohammadi N, Hajiahmadi M. Efficacy of cotrimoxazole and rifampin for 6 or 8 weeks of therapy in childhood brucellosis. Pediatr Infect Dis J. 2006;25:544–545.